Check Out BlueVoyant's ROC-Solid Advantage in the Latest eBook

Learn More
  • Home
  • Resources
  • Biotech and Pharmaceutical 2020 Report - Research Report by BlueVoyant

Biotech and Pharmaceutical 2020 Report – Research Report by BlueVoyant

BlueVoyant Report Reveals Biotech and Pharmaceutical Industry under Aggressive and Targeted Attack

As the industry ramps up global vaccine production and distribution, the report highlights the attack types and emerging threats that are likely to intensify.
Key findings include:
  • The No. 1 emerging threat in 2020 is nation-state espionage aimed at stealing COVID-19 vaccine research data. That said, the top threat overall is still ransomware.
  • COVID-19 vaccines are the crown jewels in 2020 with eight of the most prominent companies in the race for a vaccine facing high volumes of targeted malicious attacks.
  • Analysis of threat intelligence data shows that biotech and pharmaceutical companies are under massive and daily attack Of the 25 attacks reported to the media since 2017, 10 (40%) took place in 2020.
Read more around the key implications that the biotech and pharmaceutical industries are facing and how to monitor and mitigate these new attack vectors during the most critical time in their existence.

Download this Resource

Related reading

Recommended reading